Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 26, Issue 6, pp. 816-825
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 9, 2016
- Revision received December 16, 2016
- Accepted December 19, 2016
- Published first January 23, 2017.
Article Versions
- Previous version (January 23, 2017 - 07:25).
- Previous version (May 18, 2017 - 00:07).
- You are viewing the most recent version of this article.
Copyright & Usage
©2017 American Association for Cancer Research.
Author Information
- Reka Toth1,2,
- Dominique Scherer1,3,
- Linda E. Kelemen4,
- Angela Risch2,5,6,7,
- Aditi Hazra8,9,
- Yesilda Balavarca1,
- Jean-Pierre J. Issa10,
- Victor Moreno11,
- Rosalind A. Eeles12,
- Shuji Ogino13,14,15,
- Xifeng Wu16,
- Yuanqing Ye16,
- Rayjean J. Hung17,18,
- Ellen L. Goode19, and
- Cornelia M. Ulrich1,20,21,*;
- on behalf of the OCAC, CORECT*, TRICL, ELLIPSE**, DRIVE, and GAME-ON consortiaa
- 1National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 2Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 3Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.
- 4Medical University of South Carolina and Hollings Cancer Center, Charleston, South Carolina.
- 5Division of Cancer Research and Epigenetics, Department of Molecular Biology, University of Salzburg, Salzburg, Austria.
- 6Cancer Cluster Salzburg, Salzburg, Austria.
- 7Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.
- 8Brigham and Women's Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
- 9Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
- 10School of Medicine, Temple University, Philadelphia, Pennsylvania.
- 11Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
- 12The Institute of Cancer Research, London, United Kingdom.
- 13Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.
- 14Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
- 15Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
- 16Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 17Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
- 18University of Toronto, Toronto, Canada.
- 19Mayo Clinic College of Medicine, Rochester, Minnesota.
- 20Fred Hutchinson Cancer Research Center, Seattle, Washington.
- 21Huntsman Cancer Institute, Salt Lake City, Utah.
- aMembers of GAME-ON ELLIPSE.
- ↵*Corresponding Author:
Cornelia M. Ulrich, Huntsman Cancer Institute, 2000 Circle of Hope Drive Room 4165, Salt Lake City, UT 84112. Phone: 801-213-5716; Fax: 801-585-0900; E-mail: Neli.ulrich{at}hci.utah.edu
R. Toth, D. Scherer, R.J. Hung, E.L. Goode, and C.M. Ulrich contributed equally to this article.
June 2017
Volume 26, Issue 6
Volume 26, Issue 6
Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium
Jump to section
Advertisement